Results 291 to 300 of about 376,311 (300)

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

Nature Reviews Microbiology, 2009
Lanying Du, Yuxian He, Yusen Zhou
exaly  

Viruses as vaccine vectors for infectious diseases and cancer

Nature Reviews Microbiology, 2010
Simon J. Draper
exaly  

Recombinant Hepatitis B Vaccine (Engerix-B®)

Drugs, 2012
G. Keating, S. Noble
semanticscholar   +1 more source

Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy.

New England Journal of Medicine, 1984
C. Stevens, H. Alter, P. Taylor, E. Zang, E. Harley, W. Szmuness   +5 more
semanticscholar   +1 more source

Mechanical forces direct stem cell behaviour in development and regeneration

Nature Reviews Molecular Cell Biology, 2017
Kyle H Vining, David J Mooney
exaly  

HEPATITIS B VACCINATION

The Lancet, 1982
J. C. Coleman, A Hatzakis, C Anastasakos, R. Dayton, S Hadziyannis   +4 more
openaire   +2 more sources

Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection.

New England Journal of Medicine, 1982
W. Szmuness, C. Stevens, E. Harley, E. Zang, H. Alter, P. Taylor, Anita De Vera, George T. S. Chen, A. Kellner   +8 more
semanticscholar   +1 more source

Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

New England Journal of Medicine, 1982
A. Mulley, M. Silverstein, J. Dienstag
semanticscholar   +1 more source

Declines in human papillomavirus infection observed in the vaccine era

Ca-A Cancer Journal for Clinicians, 2013
exaly  

Hepatitis B Vaccine

Science, 1975
openaire   +2 more sources